Sign inJoin waitlistJoin the waitlist

Brady L. Stein

Professor, Feinberg School of Medicine · Feinberg School of Medicine

Credentials: · · · ·

History

Feinberg School of Medicine
Present

Johns Hopkins University
Until 2010
Johns Hopkins University
Until 2006
Emory University School of Medicine
2003

Research

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial
JAMA Oncology · 2018 · 347 citations
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 240 citations
Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis
Systematic review or meta-analysis · Journal of the American Geriatrics Society · 2010 · 156 citations

Brandon McMahon
15 papers
AM
Alison Moliterno
14 papers
Ruben Mesa
12 papers
Stephen Oh
11 papers
Aaron Gerds
10 papers
Jessica Altman
9 papers
Catriona Jamieson
8 papers
JS
Jerry Spivak
8 papers
Leonidas Platanias
8 papers
Martha Wadleigh
8 papers
MT
Moshe Talpaz
8 papers
RR
Raajit Rampal
8 papers · 1 as a fellow

Clinical trials

Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Principal investigator · Withdrawn · Phase 1
Northwestern University
2016
Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
Principal investigator · Withdrawn · Early phase 1
Northwestern University
2016
Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia
Principal investigator · Unknown
Northwestern University
2015–2022
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2024–2027